The announcement imo should have been declared that reiterated the take up of health care professionals is forecast to be very strong. So, Sonic now has to do more work to ensure there is adequate pathology centres ready and able to handle the tests. Therefore, the roll out now has to be more thorough than initially thought, which will take extra time. That would've at least allayed some concerns, to investors, that PromarkerD is very needed by the US healthcare system strategy for diabetics going forward.
Ann: PromarkerD US commercialisation & Promarker pipeline update, page-31
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.005(0.72%) |
Mkt cap ! $91.70M | |||
| Open | High | Low | Value | Volume |
| 70.5¢ | 71.0¢ | 69.3¢ | $130.6K | 187.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12941 | 69.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 6320 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |